Technology area: Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
BIOLOGIQ, INC. has 2 pending office actions in the Chemistry & Materials technology area. These actions are split between 2 distinct examiners and 2 distinct art units. The busiest examiner, LEE, DORIS L, is responsible for 1 pending office action, which represents half of the current active workload.
With 2 pending office actions and 2 distinct examiners, each examiner is currently handling 1 action. The involvement of 2 distinct art units indicates that the company's materials research is being evaluated under different technical classifications. This requires a prosecution strategy that accounts for the specific nuances and precedents of two different specialized groups within the USPTO.
Because the busiest examiner, LEE, DORIS L, has only 1 pending action, the portfolio's workload is balanced between the 2 distinct examiners. This distribution prevents any single examiner from having an outsized impact on the overall portfolio. Practitioners must ensure that the arguments used across the 2 distinct art units remain consistent to avoid conflicting statements during the prosecution of these related applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EASHOO, MARK | 1 | 37.3% | +35.9% |
| LEE, DORIS L | 1 | 58.7% | +8.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18492614 | THERMOPLASTIC STARCH FORMULATIONS WITH NANOPARTICLES OR FIBER ADDITIVES TO IMPART IMPROVED PROPERTIES FOR FILMS AND ARTICLES | EASHOO, MARK | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18492614 | THERMOPLASTIC STARCH FORMULATIONS WITH NANOPARTICLES OR FIBER ADDITIVES TO IMPART IMPROVED PROPERTIES FOR FILMS AND ARTICLES | EASHOO, MARK | — |
| Art Unit | Apps |
|---|---|
| 1767 | 1 |
| 1764 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18492614 | THERMOPLASTIC STARCH FORMULATIONS WITH NANOPARTICLES OR FIBER ADDITIVES TO IMPART IMPROVED PROPERTIES FOR FILMS AND ARTICLES | EASHOO, MARK | 1767 | §102§103§112 | Non-Final OA | — | Pending | Oct 23, 2023 |
| 18492611 | THERMOPLASTIC STARCH FORMULATIONS WITH ADDITIVES FOR PERFORMANCE ENHANCEMENTS | LEE, DORIS L | 1764 | §103 | Non-Final OA | — | Pending | Oct 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial